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Summary
Several receptors for human carbonic anhydrase II
(HCAII) have been prepared by covalently attaching
benzenesulfonamide carboxylates via aliphatic amino-
carboxylic acid spacers of variable length to the side
chain of a lysine residue in a designed 42 residue helix-
loop-helix motif. The sulfonamide group binds to the
active site zinc ion of human carbonic anhydrase II
located in a 15 A˚ deep cleft. The dissociation constants
of the receptor-HCAII complexes were found to be in
the range from low micromolar to better than 20 nM,
with the lowest affinities found for spacers with less
than five methylene groups and the highest affinity
found for the spacerwith sevenmethylenegroups. The
results suggest that the binding is a cooperative event
in which both the sulfonamide residue and the helix-
loop-helix motif contribute to the overall affinity.
Introduction
Biomolecular interactions involving proteins are ubiqui-
tous in nature and crucial for the function of the living
cell. Protein biosynthesis and signal transduction, for
example, depend on the ability of proteins to recognize
and bind other proteins with high affinity and specificity.
Efficient and specific small-molecule recognition of pro-
teins is a required property of successful pharmaceuti-
cals and a prerequisite for drug action.
The design and characterization of receptors that rec-
ognize and bind proteins can be expected to provide
fundamental insights into biomolecular recognition phe-
nomena in vivo and to have many applications in chem-
istry, biology, and biomedicine. Molecules capable of
recognition and binding in aqueous solution are difficult
to construct because although hydrogen bonds and
charge-charge interactions are inherently strong, they
are inefficient in water due to the complex solvation
equilibria and the high dielectric constant of the solvent
[1]. Since potential receptors must be of sufficient com-
plexity to allow multiple interactions with the protein, si-
multaneously and cooperatively, biomacromolecules
*Correspondence: lars.baltzer@kemi.uu.seare obvious candidates as starting points for receptor
design. A designed helix-loop-helix motif was reported
previously to recognize and bind the calmodulin binding
domain of calcineurin with an apparent dissociation
constant of 1 mM [2]. Organic supramolecules capable
of organizing several functional groups toward a macro-
molecular target have been shown to recognize and bind
proteins. Calixarene functionalized with peptidic loops
was reported to bind chymotrypsin and to disrupt its
interactions with protease inhibitors [3]. Protein scaf-
folds are well suited for the presentation of large, shape-
complementary hydrophobic surfaces, and surfaces that
are charge complementary, to target proteins. Small,
rigid organic residues are well suited to present preor-
ganized hydrogen bond donors and acceptors. The in-
troduction of small organic molecules in protein scaf-
folds is an attractive approach in the development of
protein receptors, provided that synthetic strategies are
available for efficient and site-selective modification of
the protein scaffold. We reported previously on a helix-
loop-helix motif thatwhen functionalized with aspacered
benzenesulfonamide ligand was capable of binding
HCAII with a dissociation constant of 20 nM [4]. The
helix-loop-helix motif was found at low micromolar con-
centration to be a dimer in aqueous solution but to bind
the protein as a monomer [5]. Hydrophobic interactions
between scaffold and protein, and the interaction be-
tween the sulfonamide group and the active site of HCAII
were to a large degree responsible for its high affinity.
This approach provides a general strategy for construct-
ing high-affinity binders from moderate ones. In biology,
modest binders are abundant, and a strategy for upgrad-
ing moderate affinity to high affinity therefore, in princi-
ple, provides an efficient route to recognition elements
for a large body of relevant biomacromolecules. Given
that the scaffolds are readily further funtionalized in
several positions, for example by covalently attaching
radiometal chelates, fluorophores, handles for immobili-
zation, PEG, active transporters, etc., or combinations
thereof, many opportunities are apparent in biotechno-
logical applications. The interactions between the func-
tionalized scaffold and HCAII have now been character-
ized to provide a platform for the further development of
this new class of receptor molecules. The importance of
spacer length and charge-charge interactions for the
recognition and binding of HCAII has been elucidated,
and the binding site has been identified. A key question
is whether the interactions between scaffold and protein,
and between sulfonamide and protein, are cooperative,
since an understanding of how to engineer cooperativity
in binding of functionalized protein scaffolds would
make it possible to construct new receptors with excep-
tionally high affinities.
Results and Discussion
The Affinities of the Receptor Molecules
Polypeptides designed to fold were synthesized and
conjugated to a series of benzenesulfonamide deriva-
tives, in which the spacer that links the ligand to the
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1246polypeptide scaffold was systematically varied. The
scaffold peptides were KE2 and TA4 (Figure 1), and
the incorporated ligands are shown in Table 1. In all con-
jugates, the spacer was covalently bound to the side
chain of Lys-34, and a dansyl fluorescent probe was co-
valently attached to the side chain of Lys-15. The affini-
ties were measured by fluorometric titration of the re-
ceptor with the target protein, HCAII, and by titration
of the HCAII receptor complex with acetazolamide in
competitive binding experiments. The affinities were
found to span approximately three orders of magnitude,
with, in general, the longer spacer giving the higher affin-
ity. The sequence KE2 has been described previously
[4]: it was designed to fold into a helix-loop-helix motif
and dimerize to form a four-helix bundle. It was further
designed to allow for the incorporation of one flurophore
and one ligand, to form a sensor peptide for screening
applications. For this reason, only two lysine residues
were allowed in close proximity to the histidine [5].
TA4 was based on the sequence of KE2, with the differ-
ence that three substituents were to be incorporated in
close proximity to the His residue and one more lysine
had to be incorporated. The scaffold sequences differ
by five residues. Three leucines in the sequence of
KE2, residues 5, 16, and 27, were replaced by norleu-
cines in the design of TA4. One lysine in the sequence
of KE2, residue 33, was replaced by an arginine in TA4,
to avoid undesirable functionalization, and one alanine
in the sequence of KE2, residue 8, was replaced by a ly-
Ac-NAADLEAAIR HLAEKLAARG PVDAAQLAEQ LAKKFEAFAR AG-OH
1 11 21 31 41
KE2
Ac-NAADJEAKIR HLAEKJAARG PVDAAQJAEQ LARKFEAFAR AG-NH2
1 11 21 31 41
TA4
Figure 1. Scaffold Sequences
The sequences of the scaffold polypeptides KE2 and TA4. Resi-
dues that differ between the sequences are shown in boldface. In
both sequences, the ligand was attached to the side chain of
Lys-34, and the fluorescent dansyl group was attached to the
side chain of Lys-15. In the peptide KE-Q, no ligand was incorpo-
rated, and a fluorescent dabcyl group was attached to the side
chain of Lys-15. Norleucines are designated as ‘‘J.’’sine in TA4 for the reasons given above. Furthermore,
the C terminus of TA4 was capped to form an amide to
ensure a total charge of +1, and thus solubility, at around
neutral pH, whereas that of KE2 was a free carboxylate,
giving a total charge of 21 at the same pH. SPR experi-
ments showed that KE2 had no measurable affinity for
HCAII, whereas TA4 bound to the protein with a dissoci-
ation constant ofw100 mM (unpublished data). We have
recently reported functionalized KE2 polypeptides to be
dimers in solution at low micromolar concentration and
to bind to the protein as monomers [6], possibly folded
into hairpin helix-loop-helix motifs. The mean residue el-
lipticities reported in Table 1 show that the functional-
ized scaffolds are highly helical and thus most likely
also dimers under the experimental conditions. The dif-
ference spectrum in which the ellipticity of the function-
alized scaffold peptide has been subtracted from that of
its complex with HCAII is compatible with helix forma-
tion [4], suggesting that it binds HCAII as a helix-loop-
helix motif. If the polypeptide is folded into a helix-loop-
helix motif, large hydrophobic surface areas can interact
with hydrophobic residues on the surface of HCAII. The
large difference in affinity between KE2 and TA4 sug-
gests that interactions between charged residues are
also important for binding.
Benzenesulfonamide is a known inhibitor of HCAII
with a Kd of 1.5 mM [7]. We reported previously on the af-
finities of a series of KE2-linked benzenesulfonamide re-
ceptors in which the ligands were bound to the scaffold
via aliphatic spacers that differed in length due to varia-
tion in the number of methylene groups [8]. The affinity
was surprisingly invariant to spacer length (Table 1) in
the case of peptides containing ligands with between
zero and for methylene groups, whereas the introduc-
tion of a fifth methylene group to form KE2-D(15)-6 in-
creased the affinity by a factor of 40. We have now in-
creased the range of spacers to determine whether the
observed affinity is due to cooperativity between the li-
gand and the scaffold, and also to elucidate the reason
for the affinity variation.
The relatively weak fluorescence intensity of the dan-
syl probe limited the experimentally accessible range
of functionalized scaffold to micromolar concentrations,
which is well above the dissociation constants of the
tightest binders. Affinities were measured by directTable 1. Structures and Affinities of Ligands for HCAII Recognition and Binding
Corresponding
Peptide
Kd/nM [Q]222 (deg$
cm2$dmol21)aBenzenesulfonamide Ligand A B C
1 H2NSO2C6H4CO-NHS KE2-D(15)-0 3000 219 600
2 H2NSO2C6H4CONHCH2CO-NHS KE2-D(15)-2 1000 219 400
3 H2NSO2C6H4CONH(CH2)3CO-NHS KE2-D(15)-4 700 219 800
4 H2NSO2C6H4CONH(CH2)4CO-NHS KE2-D(15)-5 800 218 600
5 H2NSO2C6H4CONH(CH2)5CO-NHS KE2-D(15)-6 20 23 6 2; 28 6 4 19 6 2; 13 6 2 218 200
6 H2NSO2C6H4CONH(CH2)6CO-NHS KE2-D(15)-7 10
7 H2NSO2C6H4CONH(CH2)7CO-NHS KE2-D(15)-8 4 29 6 8; 22 6 4 6 6 2; 6 6 2
7 H2NSO2C6H4CONH(CH2)7CO-NHS TA4-D(15)-8 70
8 H2NSO2C6H4CONH(CH2)10CO-NHS KE2-D(15)-11 24 6 4; 22 6 4 60 6 16; 53 6 13
Values in column A are determined from direct titration of receptor with HCAII. Values in columns B and C are determined from titration of the
HCAII-receptor complex with a competitive inhibitor. Duplicate measurements from different batches of HCAII are presented with ‘‘best fit’’ Kd
values6 1 SD. Fluorescence intensities (column B) or wavelength maxima (column C) were used to extract data. Dissociation constants for en-
tries 1–4 as well as ellipticity data from [7].
a Mean residue ellipticity at 222 nm of sensor peptides at 1 mM concentration in 100 mM sodium phosphate buffer at pH 7.4.
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titration of the HCAII-peptide complex with a competi-
tive inhibitor, acetazolamide [9]. In the latter case, disso-
ciation constants were determined by plotting both the
fluorescence intensities and the fluorescence wave-
length maxima versus concentration of acetazolamide.
The accuracy of the measurements is shown in Table
1, and the variation in affinity is significant in comparison
with the experimental variations. Even when measure-
ments were carried out with different batches of HCAII,
the experimental variations were small. In general, wave-
length maximum variations are expected to provide
more reliable results than intensity variations since in-
tensities may be affected by quenching phenomena
that are not linearly related to the dissociation equilib-
rium. Acetazolamide quenches the fluorescence from
the dansyl probe at micromolar concentrations [8], and
the largest deviations between the measurement meth-
ods were observed in the determination of the highest
affinity, that of KE2-D(15)-8, in which the largest concen-
tration of acetazolamide was needed to expel the func-
tionalized polypeptide from the binding site of HCAII.
The measured dissociation constants were 5 nM and
26 nM, depending on the method, and were reproduc-
ible. We have greater faith in the dissociation constants
obtained by direct titration or by competition measure-
ments based on wavelength shifts. Thus, results ob-
tained by measurements of intensity in the presence of
acetazolamide will be disregarded in the following sec-
tions of this manuscript.
The affinities for HCAII of receptors carrying spacers
with five methylene groups or more are all high; dissoci-
ation constants of 17, 10, and 5 nM were found for KE2-D
(15)-6, KE2-D(15)-7, and KE2-D(15)-8, respectively. The
correspondingspacerscontainfive,six, andsevenmeth-
ylene groups. The highest affinity measured for a func-
tionalized polypeptide is almost three orders of magni-
tude larger than that of benzenesulfonamide. KE2-D
(15)-11 is equipped with a spacer with ten methylene
groups and has an affinity for HCAII that is slightly less
than that of KE2-D(15)-6. The Kd was found to be 57
nM. The affinity for HCAII thus appears to be at a maxi-
mum for spacers with seven methylene groups.
We also measured the affinity of a TA4-based receptor
molecule since TA4 by itself was known to bind to HCAII
withw100 mM affinity, in contrast to that of KE2, which
was not measurable by SPR. KE2-D(15)-8 and TA4-
D(15)-8 (Table 1) both have seven methylene groups in
the spacer, and the KE2-based receptor had a Kd of
5 nM. The corresponding TA4-linked receptor had an af-
finity that was 14-fold less, a result that demonstrated
that there was a significant effect from the polypeptide
scaffold on the overall affinity. The observation of a
weaker affinity for HCAII of the TA4-based receptor than
of the KE2-based receptor, in spite of the fact that un-
functionalized TA4 has higher affinity than unfunctional-
ized KE2, suggests that the scaffolds do not bind in the
same way to HCAII when attached to the ligand as
when unmodified. It should also be taken into consider-
ation that upon acylation of two lysine residues, the total
charges of both the KE2 and TA4 scaffolds are reduced
by two, and that this may cause a loss of affinity and alter
the binding site in comparison with those of the unsubsti-
tuated scaffolds.NMR Spectroscopic Investigations of Receptor-
Protein Complexes
HSQC spectroscopic investigations of 15N-labeled pro-
teins in the presence of small-molecule ligands are com-
monly used to probe small molecule-protein interactions
with the specific goal of searching for weak interactions
[10]; ‘‘weak’’ is defined as affinities with dissociation
constants in the millimolar to micromolar range. The 1H
and 15N NMR spectra have been assigned for HCAII
[11], and the interactions between scaffolds and HCAII
and functionalized scaffolds and HCAII were studied
by recording the HSQC spectra of free HCAII and of mix-
tures of HCAII and receptor molecules, typically in a 1:1
ratio at 50 mM concentrations by using cryoprobe tech-
nology at 600 MHz (Figure 2). Shifts in the 1H or 15N di-
mensions larger than 10 Hz were considered perturba-
tions since the chemical shifts of the amide proton and
nitrogen atoms of HCAII in seven different samples of
HCAII under native conditions were62.5 Hz in the proton
dimension and 61.5 Hz in the nitrogen dimension (M.L.,
unpublished data). Several amide resonances were
shifted in the presence of the receptor molecules, and
from the assigned HCAII spectrum [11], it was possible
to identify the affected residues and to obtain informa-
tion about the site of binding on the HCAII surface.
Unmodified KE2 did not affect the chemical shifts of
HCAII, whereas unmodified TA4 did, in agreement with
the relative affinities measured by SPR. Due to the weak
affinities of the scaffolds for HCAII, these measurements
were carried out at 100 mM concentration of HCAII and
200 mM concentration of TA4 and KE2. Among the func-
tionalized scaffolds, no shifts were observed for KE2-
D(15)-5, a receptor with a Kd of 800 nM, but strong shifts
were observed for KE2-D(15)-6, with a Kd of 17 nM. KE2-
D(15)-8 bound even stronger to HCAII than KE2-D(15)-6
(Table 1), but the perturbations of HCAII chemical shifts
were less pronounced. In Figure 3, the structure of HCAII
Figure 2. Identification of Binding Site
Overlay of HSQC spectra of 50 mM 15N-labeled HCAII in aqueous
solution at pH 7 and of 50 mM 15N-labeled HCAII in the presence
of 50 mM KE2-D(15)-6. Red crosspeaks are from free HCAII, blue
crosspeaks are from the 1:1 mixture, and some peaks show a
lack of overlap due to complexation with the receptor molecule.
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tionalized Helix-Loop-Helix Receptors Is
Manifested by Strong Perturbations of the
HCAII Surface
Illustration of binding of HCAII by KE2-D(15)-6
and by KE2-D(15)-8, in which the amide nitro-
gens of residues perturbed by complexation
are shown in space-filling mode. Yellow nitro-
gens show residues that are affected by both
receptors, residues affected by KE2-D(15)-8,
but not by KE2-D(15)-6, are shown in red,
and residues affected only by KE2-D(15)-6
are shown in blue. The shorter spacer of
KE2-D(15)-6 causes larger perturbations of
the target protein than does that of KE2-
D(15)-8. A shift is registered if the chemical
shift is changed by 10 Hz or more. The figure
was prepared by using the program MOLMOL
[18]. Inset: As an illustration of the relative
sizes of HCAII and the scaffold, a modeled
structure of TA4 is compared to that of the
crystal structure of HCAII.is shown with the residues affected in the presence of
KE2-D(15)-6 and KE2-D(15)-8 highlighted to illustrate
the interaction between the scaffold and HCAII. The res-
idues that are affected are located in the central hydro-
phobic cluster and on the surface of the protein in the
neighborhood of the active site, and they include hydro-
phobic as well as polar and charged residues. The per-
turbations on the surface of HCAII covered an area that
is large, but they correspond approximately to what
would be expected from an interaction between HCAII
and a helix-loop-helix motif (Figure 3). The size of the
folded helix-loop-helix motif isw20 3 25 A˚, and that of
HCAII is 47 3 41 A˚ [12], which makes the two proteins
of comparable size. Thus, it is not surprising that the
chemical shift perturbations are found over a large
area of HCAII. The receptor with the longest spacer,
KE2-D(15)-11, gave rise to severe perturbations of the
amide groups (Figure 4) in spite of the fact that its affinity
was less than that of other receptor molecules with more
than four methylene groups in the spacer; however, in
this case, the interaction was found to be more complex.
In the case of the longest spacers, there was a pro-
nounced reduction in the overall intensity of the NMR
spectrum, an effect that may be due to further aggrega-
tion of the receptor-HCAII complexes. Only 30% of the
overall intensity remained in the spectrum of HCAII after
the addition of KE2-D(15)-11, an observation that is in
agreement with the hypothesis that there is more than
one HCAII and possibly more than one receptor in the
complex, which has a resulting molecular weight of 70
kDa or more. Under these conditions, the resonancesfrom aggregated proteins would be broadened beyond
detection, and only the fraction of protein that remains
nonaggregated would be observable. An approximate
30% loss of HCAII intensity was observed in the pres-
ence of KE2-D(15)-8.
The observation that KE2-D(15)-5 did not perturb the
chemical shifts of the amide residue and showed
a weak affinity, whereas KE2-D(15)-6 perturbed the
chemical shifts severely and showed high affinity, sug-
gests that the polypeptide scaffold cannot form a helix-
loop-helix motif when bound to HCAII if the spacer is
too short. While we have no direct structural evidence
for this hypothesis, the crystal structure of HCAII [12]
shows that the active site is located in a 15 A˚ deep cleft
that appears not to be able to accommodate a folded
helix-loop-helix motif, but canpossibly accommodatean
unordered polypeptide chain. The ligand was attached
to the side chain of Lys-34; thus, most of the polypeptide
chain, if unordered, can extend from the active site into
the solution. There are no chemical shift perturbations
for any of the residues in the binding pocket to suggest
that the active site has been rearranged upon binding to
KE2-D(15)-5 to accommodate the bulky helix-loop-helix
motif. It is therefore likely that in the complex formed be-
tween HCAII and KE2-D(15)-5 the interaction between
the active site zinc ion and the benzenesulfonamide resi-
due dominates, the helix-loop-helix motif is not formed,
and the structure of HCAII remains intact. The affinities re-
main largely constant for the short spacers, which is in
agreement with this model. With longer spacers, the scaf-
fold can fold in the complex. In the case of KE2-D(15)-6,
Polypeptide Chimera Receptors
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Spacered Receptor
Illustration of binding of KE2-D(15)-11 to
HCAII, in which the amide nitrogens of resi-
dues perturbed by complexation are shown
in space-filling mode. A shift is registered if
the chemical shift is changed by 10 Hz or
more. The figure was prepared by using the
program MOLMOL [18].the scaffold can fold under considerable perturbation of
the target protein. With an even longer spacer, as in KE2-
D(15)-8, the binding to HCAII is strong, but the perturba-
tion is less, possibly because the receptor molecule has
a more well-defined interaction with the binding site of
HCAII. For the longest spacer studied, the perturbations
are again severe, showing that the interactions between
scaffold and the hydrophobic patch are also important
in this case although the affinity is slightly reduced.
While we have not fully characterized the state of ag-
gregation of the HCAII-receptor complexes with the lon-
gest spacers, we have been able to exclude the possibil-
ity that ternary complexes are formed in which one
HCAII binds two receptor polypeptides. The dissocia-
tion constant for the ternary complex between HCAII,
KE2-D(15)-6, and the polypeptide KE2-Q was deter-
mined and was found to be 286 mM. KE2-Q has the
same sequence as KE2, but there is no benzenesulfona-
mide attached, and the dansyl probe has been replaced
by 4-(4-dimethylamino-phenylazo)-benzoate (dabcyl), a
known quencher of fluorescence. Under the assumption
that KE2-Q forms a heterodimer with KE2-D(15)-6, with a
dissociation constant that is similar to that of the homo-
dimer of KE2-D(15)-6, KE2-Q can be used to probe ter-
nary complex formation. The dissociation constants
for the ternary complexes with HCAII and KE2-Q were
105 mM and 87 mM for KE2-D(15)-8 and KE2-D(15)-11, re-
spectively. Consequently, under the experimental con-
ditions for affinity measurements, very little was formed
of the ternary complexes involving two receptor pepti-
des and one HCAII molecule. Also, the observed loss
of NMR intensity upon complexation is only compatible
with the formation of a high-molecular weight species,
suggesting more than one HCAII per complex.The Cooperative Binding of HCAII by Functionalized
Polypeptide Scaffolds
In the cooperative binding of a protein by a receptor
molecule, in which several groups bind simultaneously
to specific residues on the protein surface, the overall
binding energy amounts to at least the sum of the con-
tributions from each individual interaction. If a protein
scaffold with some affinity for a target protein is cova-
lently functionalized with a small molecule that is also
capable of binding to the target protein, and if the small
molecule is linked in a way that allows both the scaffold
and the small molecule to bind simultaneously, the func-
tionalized protein scaffold will show an affinity that is
larger than that of the small molecule. It will, in principle,
act as a receptor that has a dissociation constant that is
at least the product of the two individual dissociation
constants, but it may have a dissociation constant that
is considerably lower, for entropic reasons. The mea-
sured affinities of the polypeptide benzenesulfonamide
conjugates with five or more methylene groups in the
spacer are all larger than that of benzenesulfonamide it-
self. The observed affinities suggest that the scaffold
and benzenesulfonamide bind cooperatively to HCAII.
The longer and more flexible the spacer, the smaller
the entropic advantage, since the level of preorganiza-
tion is less. The observation of a maximum binding affin-
ity as a function of spacer length is compatible with a co-
operative binding behavior. An alternative explanation
for the weaker affinity found in the complex between
HCAII and the receptor molecule with the longest spacer
may, however, be that the preferred binding modes of
the benzenesulfonamide group and the scaffold cannot
accommodate an unstrained methylene spacer to con-
nect the two. The difference in affinity is less than a factor
Chemistry & Biology
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TA4-D(15)-8
Illustration of binding of TA4 and of TA4-
D(15)-8 to HCAII. The yellow nitrogens are
those of residues affected by binding of both
receptors, the red nitrogens are those of res-
idues affected only by TA4, and the blue nitro-
gens are those affected only by TA4-D(15)-8.
The binding site of TA4 is more distant from
the active site of HCAII than that of TA4-
D(15)-8, showing that, in the latter case, the
scaffold does not, and probably cannot,
bind in the site for which the 100 mM dissocia-
tion constant was measured. The Cut-off limit
for a chemical shift change is 10 Hz. If a lower
cut-off than 10 Hz is used for TA4 to compen-
sate for the weaker binding, it nevertheless
shows that the binding site of TA4 deviates
significantly from that of TA4-D(15)-8. The
figure was prepared by using the program
MOLMOL [18].of ten, and the corresponding difference in free energy is
comparable to that found for different conformers of al-
iphatic residues.
The observation of a perturbed surface area on HCAII
shows that in the receptors with long spacers the scaf-
folds bind to the target protein. The complete lack of ob-
servable perturbed residues in the complex formed from
HCAII and KE2-D(15)-5 provides strong evidence that, in
this case, the scaffold does not bind, and that binding in-
teractions are required for shift perturbations. The differ-
ence in binding is reflected in a more than two orders of
magnitude difference in affinity (Table 1). The sulfon-
amide binds to the active site zinc ion in all cases. Al-
though the observed affinities are very similar to those
reported for benzenesulfonamide derivatized with ali-
phatic substituents [13], the NMR spectroscopic results
clearly demonstrate that there is an interaction between
polypeptide and HCAII, and, therefore, that the binding
is cooperative. The difference in binding affinity between
that of KE2-D(15)-8 and that of TA4-D(15)-8 strengthens
the conclusion that the scaffold participates in bind-
ing. The introduction of a methoxycoumarine derivative
into position 25 of KE2-D(15)-6 was shown previously
to enhance the affinity of the functionalized polypeptide
by approximately a factor of four [6].
It was shown by Jain et al. that benzenesulfonamides
modified with aliphatic and aromatic substituents ex-
hibited considerably higher affinities for HCAII than the
unsubstituated compounds, probably due to hydropho-
bic interactions in the binding pocket. Affinities in the
range of 1–5 nM were obtained in 20 mM phosphate
buffer at pH 7.4 [13]. It could be argued that the affinity
increase observed for the protein scaffolds in Table 1
is due to similar effects, but the observation of an affinity
maximum is not expected from such a binding model,
and no evidence was obtained from NMR spectroscopy
to support such a conclusion. In no complex were per-
turbations of residues located in the binding pocketobserved, which would be expected if there were inter-
actions between spacer and hydrophobic amino acid
residues in analogy with those reported for the benzene-
sulfonamide derivatives with alifatic spacers [13].
Unmodified KE2 does not bind to HCAII, but when
linked to a spacered sulfonamide the scaffold binds to
a hydrophobic patch close to the active site. The obser-
vation of chemical shift changes in HCAII in the presence
of KE2-D(15)-6, but not in the presence of KE2, indicates
that the proximity of the scaffold to the protein in the for-
mer enhances its affinity for HCAII, most likely for entro-
pic reasons. TA4-D(15)-8 showed a Kd of 70 nM, an order
of magnitude larger than that of the KE2-linked receptor,
although TA4 by itself binds more strongly to HCAII than
KE2. The HSQC spectrum revealed the reasons for the
unexpected weak affinity (Figure 5). A comparison be-
tween the perturbation pattern induced by TA4 with
that induced by TA4-D(15)-8 shows that in the case of
the latter the scaffold does not bind at the same site
as TA4. It is possible that the spacer restricts the access
of the scaffold to its preferred binding site, and that a lon-
ger spacer, or an alternative linkage position, would give
rise to higher affinity.
Significance
Functionalization of folded polypeptides with ligands
of modest affinity for a target protein can serve as a
strategy for the design of receptors in which the over-
all affinity is higher than that of the ligand due to coop-
erative effects. In addition to providing fundamental
insights into the thermodynamics of multidentate re-
ceptormolecules that recognize proteins, these recep-
tors areenvisioned tohaveaplethoraof applications in
drug screening, bioseparation, and protein chip fabri-
cation. These molecules are robust, have high affinity,
and should, in principle, have the potential to provide
better than nanomolar affinities for proteins, provided
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ture and the ligand linkage site can be identified. From
the point of view of receptor design, a spacer that is
too short may drastically reduce the overall affinity,
whereas a spacer that is too long may give rise to un-
wanted aggregation and ambiguous results, although
the apparent affinity may not be much affected.
Experimental Procedures
Peptide Synthesis and Purification
The peptides were synthesized on a Pioneer automated peptide
synthesizer (Applied Biosystems) by using standard fluorenylme-
thoxycarbonyl (Fmoc) chemistry with O-(7-benzotriazole-1-yl)-
1,1,3,3-tetramethyluronium tetrafluoroborate (TBTU, Alexis Bio-
chemicals) and diisopropylethylamine (DIPEA, Applied Biosystems)
as activating agents. The synthesis was performed on a 0.1 mmole
scale, with a PAL-PEG-PS resin giving a C-terminal amide upon
cleavage; a 4-fold excess of amino acid was used in each coupling.
The side chains of the amino acids (Calbiochem-Novabiochem AG)
were protected by base-stable groups: tert-butyl ester (Asp, Glu),
tert-butoxymethyl (Lys), trityl (His, Asn, Gln), and 2,2,4,6,7-pentam-
ethyldihydrobenzofuran-5-sulfonyl (Arg). Lys-15 was protected by
allyloxycarbonyl (Aloc). The N terminus was capped with 0.3 M ace-
tic anhydride in DMF. Prior to cleavage, the Aloc group of Lys-15 was
selectively deprotected by using three equivalents of tetrakis(triphe-
nylphosphine)palladium(0) (Pd(Ph3)4) dissolved in a mixture of N-
methylmorpholine, acetic acid, and trichloromethane (5:10:85, 10
ml per gram of resin). After 2 hr at room temperature, in darkness,
the resin was alternately rinsed with 0.5% sodium diethyldithiocar-
bamate (DEDT) in DMF and 0.5% DIPEA in DMF. The dansyl probe
was coupled by adding six equivalents of DIPEA and three equiva-
lents of 5-dimethylamino-naphthalene-1-sulfonyl chloride in DMF.
After 1 day at room temperature, the resin was rinsed with DCM
and dried under nitrogen. The peptides were cleaved from the resin
by treatment with a mixture of trifluoroacetic acid (TFA), water, and
triisopropylsilane (95:2.5:2.5 v/v, 10 ml per gram of polymer) for 3 hr
at room temperature. After filtration and concentration, the peptide
was precipitated by the addition of cold diethyl ether, centrifuged,
washed in diethyl ether, and dried under nitrogen. The crude pepti-
des were purified by revers-phase HPLC on a semipreparative C-8
HICHROM column, eluted with 37%–45% isopropanol and 0.1%
TFA in water at a flow rate of 10 ml/min. Collected fractions were
identified by MALDI-TOF mass spectrometry, concentrated, and ly-
ophilized. The peptides were dissolved to a concentration of 1 mM in
50 mM sodium phosphate (pH 8.0), and Lys-34 was selectively mod-
ified with 1.5 equivalents of the benzenesulfonamide derivate. The
dabcyl probe used for the quencher experiments was coupled on
the solid phase to a peptide with Lys-15 deprotected as described
above by mixing for 1 day with three equivalents of the active ester
4-(4-dimethylamino-phenylazo)-benzoic acid benzotriazol-1-yl es-
ter in situ synthesized from 4-(4-dimethylamino-phenylazo)-benzoic
acid, diisopropylamine, 1-hydroxybenzotriazol, and benzotriazol-1-
yl-oxy-tris-pyrrolidino-phosphonium hexafluorophosphate (PyBOP).
Cleavage and workup are as described above.
Synthesis of Benzenesulfonamide Derivatives
H2NO2SC6H4CO-NHS (1)
4-carboxybenzenesulfonamide (3.70 g, 18.4 mmole) and N-hydroxy-
succinimide (NHS, 2.11 g, 18.3 mmole) were dissolved in a mixture of
37 ml dioxane and 15 ml N,N-dimethylformamide (DMF) and were
cooled in an ice bath. Dicyclohexylcarbodiimide (3.80 g, 18.4 mmole)
was added to the solution, and the reaction mixture was stirred for
10 min and then left overnight at 4ºC. Precipitated N,N-dicyclohexyl-
urea (DCU) was removed by filtration. The solvent was reduced to an
oil, and crystallization from 50 ml warm 2-propanol afforded a white
solid (24.40 g, 81%) in two crops. Purity was confirmed by 1H-NMR
(300 MHz, CDCl3, 25ºC).
General Procedure for the Synthesis of H2NO2SC6H4CONH
(CH2)nCO-NHS, n = 1, 3, 4, 5, 6, 7 (2–7)
To a 0.2 M solution of (1) in acetone was added one equivalent of
nucleophile (glycine, 4-aminobuturic acid, 5-aminopentanoic acid,
6-aminohexanoic acid, 7-aminoheptanoic acid, 8-aminooctanoicacid) as a 0.3 M solution in 50 mM sodium borate (pH 8.5). The reac-
tion mixture was stirred at room temperature for at least 2 hours
while the pH was kept between 7.0 and 7.5. The solution was acidi-
fied and reduced in vacu. The intermediate carboxylic acid product,
H2NO2SC6H4CONH (CH2)nCOOH, was washed in cold water and
dried. Yields were between 62% and 92%, and purity was confirmed
by 1H-NMR. To prepare the NHS esters, one equivalent of the inter-
mediate product was added to 1.1 equivalent of NHS (0.1 M) dis-
solved in a 1:1 dioxane:DMF mixture at 0ºC. One equivalent of
DCC was added to the solution, and the reaction mixture was stirred
overnight at 5ºC. DCU was removed by filtration. The solvent was re-
duced, and crystallization from 2-propanol and hexane afforded
a white solid. Purity was confirmed by 1H-NMR, and the yields
were between 36% and 67%.
Procedure for the Synthesis of H2NO2SC6H4CONH
(CH2)10CO-NHS (8)
A suspension of 11-aminoundecanoic acid (0.108 g, 0.536 mmole) in
acetone (2.4 ml) and 50 mM sodium borate (1.6 ml) was adjusted by
the addition of aqueous hydrochloric acid (1.2 M) to pH 9. The sus-
pension was added to (1) (0.160 g, 0.536 mmole). The reaction mix-
ture was stirred at room temperature for 24 hr while the pH was kept
between 7.0 and 8.5 by adding aqueous sodium hydroxide (1 M), and
the suspension was kept fluent by the addition of a 4 ml water/ace-
tone mixture (2:3). The solution was acidified by addition of aqueous
hydrochloric acid (2 ml, 1.2 M), frozen, and lyophilized. The interme-
diate carboxylic acid product, H2NO2SC6H4CONH (CH2)10COOH,
was washed with water (25 ml) and dried. A white powder was iso-
lated (0.164 g, 80%), and purity was confirmed by 1H-NMR. The NHS
ester was prepared from the carboxylic acid (0.159 g, 0.414 mmol) as
described in the general procedures, with the exception that crystal-
lization was made from boiling 2-propanol (15 ml). A white powder
was isolated (117 mg, 59%), and purity was confirmed by 1H-NMR.
NMR Spectroscopy
The NMR samples were 50 mM uniformly 15N-labeled human car-
bonic anhydrase II (produced and purified as described by Ma˚rtens-
son et al. [14]) in 10 mM phosphate buffer (pH 7.4) with a 90:10 ratio
of H2O:D2O. The temperature was kept at 25ºC during the experi-
ments. The peptides KE2-D(15)-5, KE2-D(15)-6, KE2-D(15)-8, and
TA4-D(15)-8 were added to give a 1:1 ratio between protein and pep-
tide and more than 95% complex formation. KE2 and TA4 were
added to give a 1:2 ratio between protein and peptide to maximize
complex formation that was less than 95% due to weak affinities.
The NMR measurements were performed on a Varian Inova Unity
600 MHz NMR spectrometer equipped with a triple resonance
cryo-probe. The backbone of the protein was monitored by 2D-
HSQC NMR in the sensitivity-enhanced gradient version as de-
scribed by Kay et al. [15]. The 2D data were processed by using
the program nmrPipe [16], and the spectra were analyzed with the
program SPARKY [17].
Fluorescence Spectroscopy with Direct Titration
Analyses were carried out on a F-4500 spectrofluorophotometer (Hi-
tachi High-Technologies Corp.) in a 1 cm quartz cuvette. The excita-
tion wavelength was 335 nm, and the emitted fluorescence was
measured at 450–650 nm. Excitation and emission slits were 5 nm.
Stock solutions of peptides were prepared in distilled water, and
the concentration was determined from the absorbance of the dan-
syl group at 335 nm by using 3 = 4200 cm21M21. The stock solutions
were diluted by HEPES-buffered saline (10 mM HEPES, 150 mM NaCl
[pH 7.4]; from Biacore AB). For affinity determinations, samples of
0.2 mM peptide concentration were titrated with solutions of 0.1, 1,
and 10 mM HCAII diluted from a stock solution of 500 mM in HEPES-
buffered saline. The concentration of the HCAII stock solution was
determined from the absorbance at 280 nm by using 3 = 54 800
cm21M21. The fluorescence of dansyl at 510 nm was monitored
as a function of total protein concentration, and the dissociation con-
stant, Kd, was determined by fitting Equation 1 to the experimental
results under the assumption of a 1:1 binding model.
Fobs =
Fbound$[CA] + Ffree$Kd
[CA] + Kd
: (1)
Fobs is the observed fluorescence intensity, Fbound is the fluores-
cence of the peptide bound to HCAII, Ffree is the fluorescence of
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[CA] can be derived from Equation 2:
[CA] = 2
Ptot + Kd2CAtot
2
+
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Ptot + Kd2CAtot
2
2
+ Kd$CAtot
s
; (2)
where Ptot is the total concentration of peptide, and CAtot is the total
concentration of HCAII. Curve fitting was done with Igor Pro 4.03
software (WaveMetrics, Inc.).
Fluorescence Spectroscopy Using Titration
with Competitive Inhibitor
Analyses were carried out on a FluoroMax-2 spectrofluorophotome-
ter (Instruments S. A., Inc.) in a 1 cm quartz cuvette. The excitation
wavelength was 335 nm, and the emitted fluorescence was mea-
sured at 465–545 nm or 475–555 nm. The excitation and emission slits
were 2 and 5 nm, respectively. Stock solutions of peptides were pre-
pared as described above. The peptide stock solutions were diluted
with HEPES-buffered saline (10 mM HEPES, 150 mM sodium chloride
[pH 7.4]; from Biacore AB), and pH was adjusted to 7.4 by the addition
of aqueous sodium hydroxide. Stock solutions of HCAII and acet-
azolamide were prepared in HEPES-buffered saline, and pH was ad-
justed to 7.4. The concentration of the HCAII stock solution was
determined from the absorbance at 280 nm by using 3 = 54 800
cm21M21. For affinity determinations, samples of 2 mM peptide sol-
utions and 1 mM HCAII solutions were titrated with solutions of 4.8,
22, 112, and 800 mM acetazolamide containing 2 mM peptide and
1 mM HCAII prepared by dilution of stock solutions with HEPES-
buffered saline. The fluorescence of the dansyl group was monitored
as a function of the total acetazolamide concentration, and the dis-
sociation constant, Kd, was determined by fitting Equation 3 to the
experimental results under the assumption of a 1:1 binding model:
Fobs =
Fbound$[CAP] + Ffree$[P]
[CAP] + [P]
: (3)
Depending on the Mode of Data Extraction
Fobs is the observed maximum fluorescence intensity or the wave-
length of maximum fluorescence, Fbound is the fluorescence or the
wavelength of maximum fluorescence of the peptide bound to
HCAII, and Ffree is the fluorescence or the wavelength of maximum
fluorescence of the unbound peptide. [CAP] is the concentration
of peptide bound to HCAII, and [P] is the concentration free peptide.
[CAP] and [P] can be derived from Equation 4:
[CAP]3 +
Kd$(Itot2Ptot2CAtot2Kd)+Ki$(Kd +2$Ptot +CAtot)
Kd2Ki
$[CAP]2
+
Ptot$[Kd$(CAtot2Itot)2Ki$(Kd +Ptot +2$CAtot)]
Kd2Ki
$[CAP]
+
Ki$CAtot$P
2
tot
Kd2Ki
=0
[P] =Ptot2[CAP]; (4)
wherePtot is the total concentration of peptide,CAtot is the total con-
centration of HCAII, Itot is the total concentration of acetazolamide,
and Ki is the dissociation constant of the HCAII-acetazolamide com-
plex. The solution to this cubic equation can be found in the Supple-
mental Data (contained in the article online). Curve fitting was done
with Igor Pro 4.03 software (WaveMetrics, Inc.).
Supplemental Data
Supplemental Data including the solution of the cubic equation
needed for analysis of the data are available at http://www.chembiol.
com/cgi/content/full/12/11/1245/DC1/.
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